Document:

Exhibit 10.26

 

AMENDMENT NO. 4 TO LICENSE AGREEMENT

 

THIS
AMENDMENT NO. 4 TO LICENSE AGREEMENT is made as of the 25th day of March,
2004 by and between BENTLEY PHARMACEUTICALS, INC., a Delaware corporation,
with offices at Bentley Park, 2 Holland Way, Exeter, New Hampshire 03833
(hereinafter, “BENTLEY” or “Licensor”), and AUXILIUM PHARMACEUTICALS, INC.
(formerly Auxilium A2, Inc.), a Delaware corporation having a principal
place of business at 160 W. Germantown Pike, Norristown, Pennsylvania 19401
(hereinafter, “AUXILIUM” or “Licensee”). BENTLEY and AUXILIUM may be
referred to as a “Party” or, collectively, as “Parties.”

 

RECITALS

 

WHEREAS
the parties have entered into that certain License Agreement, dated May 31,
2000, relating to the grant by BENTLEY to AUXILIUM of a license of certain
technology (the “License Agreement”);

 

WHEREAS
the parties clarified certain aspects of the License Agreement by entering into
Amendment Nos. 1, 2 and 3 to the License Agreement, dated October 31,
2000, May 31, 2001 and September 6, 2002, respectively (“Previous
Amendments”); and

 

WHEREAS,
BENTLEY would like to provide incentives to AUXILIUM to enter into sub-licenses
for the Products in territories outside the United States; and

 

WHEREAS
the Parties wish to further amend the License Agreement to clarify certain
sections of the License Agreement;

 

NOW,
THEREFORE, in consideration of the promises and mutual covenants contained
herein, and INTENDING TO BE LEGALLY BOUND HEREBY, the Parties further amend the
License Agreement as follows:

 

ARTICLE I

DEFINITIONS

 

1.1
Except as amended below, the terms defined in the License Agreement, as amended
by the Previous Amendments, shall remain unchanged. Unless otherwise defined in
this Amendment, all capitalized terms in this Amendment shall have the meanings
ascribed to them in the License Agreement, as amended by the Previous
Amendments.

 

“Net
Sales Price” means, with respect to the Product, the gross amount invoiced by
Licensee for such Product, less deductions for:

 

(i) returned
goods; (ii) trade and quantity discounts; (iii) rebates, including
those in respect of any governmental subsidized program, rebate payments given
to wholesalers, buying groups, healthcare insurance carriers or other
institutions; (iv) sales or other taxes actually paid by Licensee or its
sublicensee or distributor, not including taxes assessed on the income
resulting from such sales; and (v) freight allowances, insurance and
customs duties, to the extent any of the foregoing are identified on the
invoice for the Product. If Product is sold for consideration other than cash,
the fair market value of such other consideration shall be included in Net
Sales. If a Product is sold in a package or kit containing another product

 

1

 

which
is not a Product, the Net Sales price for purposes of calculating the royalty
under Section 3.2 hereof shall be calculated by multiplying the Net Sales
Price of the combination product by the fraction of A/A+B, where “A” is the Net
Sales Price of Product when sold separately “B” is the Net Sales Price of the
other product or products when sold separately. If either the Product or the
other product is not sold separately, the Net Sales Price of the Product shall
be negotiated in good faith by the Parties.

 

“Commercial
Sale” means the sale of Product (as indicated by shipment of Product) to an
unaffiliated third-party of the Licensee, or of its sublicensee or distribution
partner, such as a wholesaler, managed care organization, hospital or pharmacy
and shall exclude (i) any transfer of Product by Licensee to its
sublicensee, distribution partner or Affiliate and (ii) any distribution
of Product for use in research, development, pre-clinical and clinical trials.

 

ARTICLE II

PAYMENTS IN CONSIDERATION FOR LICENSE

 

2.1
Except as amended below, all payments set forth in Article III of the
License Agreement shall remain unchanged.

 

2.2
Section 3.2 of the License Agreement is hereby amended to include the
following additional paragraph (d):

 

“(d) Notwithstanding
any contrary provisions in this Section 3.2, the royalty payments due
under Sections 3.2 (a), (b) or (c) above shall be paid on a
country-by-country basis only until the later of (i) the termination of
Bentley Patent rights in such country or (ii) ten years from the date of
first Commercial Sale of Product in such country.

 

ARTICLE III

CERTAIN OBLIGATIONS OF LICENSEE

 

3.1
A new Section 4.4 shall be added to the License Agreement as follows:

 

4.4
Drug Master File. Licensee shall make certain data generated during the
research and development of Testim accessible to Licensor through the
preparation and filing of one or more Drug Master Files (“DMF”). Such DMF shall
(a) be filed by or on behalf of the Licensee with the United States Food
and Drug Administration (“FDA”) on or before June 30, 2004 and (b) shall
contain the data listed on the index attached as Exhibit A to this
Amendment 4 to the License Agreement (the “Data Index”). Licensee will
designate Licensor, or its licensee if requested in writing by Licensor, as
having a right of reference with the FDA to the DMF (the “Right of Reference”).
Licensor shall treat the Data Index as confidential information of Licensee and
may disclose the Data Index only to those persons or third parties who
have agreed in writing to maintain its confidentiality and to use the Data
Index solely for purposes of evaluation of a potential business opportunity
with Licensor.

 

ARTICLE IV

PATENTS, TRADEMARKS AND INFRINGEMENT

 

4.1
Section 9.2(a) of the License Agreement shall be deleted in its
entirety and replaced with the 

 

2

 

following:

 

(a) In
the event of Licensor wishing to abandon any BENTLEY Patents, Licensor will
offer to assign to Licensee or a sublicense of Licensee, at Licensee’s option,
free of charge, any such Patent prior to effectuating the abandonment. Licensee
will bear the costs connected to any assignment hereunder.

 

4.2
A new Section 9.6 shall be added to the License Agreement as follows:

 

9.6
Bentley Trademark. In cooperation with Licensee, Licensor shall register in
the United States Patent and Trademark Office and such other countries of the
world where the trademark is registrable, a trademark to be used to describe
the unique qualities of the technology contained in the Bentley Patents (the “New
Trademark”). Licensee shall have a perpetual, royalty free, worldwide, sole and
exclusive license with the right to sublicense, to use the New Trademark in
connection with the Product or any other product, patents, technology or
similar rights licensed from Licensor now or in the future which contain the
ingredient pentadecalactone. Nothing in this Section 9.6 shall prevent
Licensee from using or registering any trademark of its own in connection with
the Product or any characteristic of or ingredient in the Product.

 

ARTICLE V

TERM AND TERMINATION

 

5.1
Except as amended below, all provisions of Article XI Term and Termination
of the License Agreement shall remain unchanged.

 

5.2
Section 11.1 of the License Agreement shall be deleted in its entirety and
replaced with the following:

 

11.1
Term. This Agreement and the licenses granted herein shall commence on the
Effective Date and shall continue until all royalty obligations of Licensee
under Section 3.2 of this Agreement are ended, subject to earlier
termination under Section 11.2 hereof. Once all such royalty obligations
of Licensee have ended Licensee shall have a fully paid up license under this
Agreement.

 

5.3
Section 11.2 (a) of the License Agreement shall be deleted in its
entirety and replaced with the following:

 

(a) Upon
the occurrence of any of the events set forth below (“Events of Default”), the
Licensor shall have the right to terminate this Agreement by giving written
notice of termination, such termination effective with the giving of such
notice:

 

(i) In
the event of nonpayment of any material amount payable to the Licensor after
completion of an audit provided for under Section 3.5 hereof, which
nonpayment is continuing thirty (30) calendar days after the Licensor gives
Licensee written notice of such non-payment.

 

(ii) In
the event that Licensee fails to initiate clinical trials within two (2) years
of availability of final formulation in quantities adequate for clinical
testing and associated documentation for clinical trials, unless such failure
is outside of the control of Licensee. See Auxilium Development Plan attached
as Schedule C hereto.

 

3

 

(iii) In
the event that Licensee does not submit an application for marketing approval
in a major market within a five (5) year period after the Effective Date
unless such failure to submit is outside of the control of Licensee.

 

(iv) In
the event that Licensee becomes subject to a Bankruptcy Event provided, however,
that so long as Licensor continues to receive royalty payments from Licensee
under this Agreement, such Bankruptcy Event shall not be a basis for
termination of this Agreement by Licensor.

 

ARTICLE VI

ADDITIONAL PROVISION

 

6.1
Section 13.5 of the License Agreement shall be deleted in its entirety and
replaced with the following:

 

13.5
Notices. Any notice under this Agreement shall be sufficiently given if
sent in writing by overnight courier, prepaid, first class, certified or
registered mail, return receipt requested, addressed as follows:

 

If
to the Licensor, to:

 

BENTLEY
PHARMACEUTICALS, INC.

Bentley
Park

2
Holland Way

Exeter,
New Hampshire 03833

Attention:
President

 

If
to the Licensee, to:

 

AUXILIUM
PHARMACEUTICALS, INC.

160
W. Germantown Pike

Norristown,
PA 19401

Attention:
President

Copy
to General Counsel

 

or
to such other addresses as may be designated from time to time by notice
given in accordance with the terms of this Section.

 

IN
WITNESS WHEREOF, the parties hereto have duly executed this Amendment No. 4
to License Agreement as of the date first above written.

 

 

	
  BENTLEY
  PHARMACEUTICALS, INC.

  	
  AUXILIUM
  PHARMACEUTICALS, INC.

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
  /s/    James
  R. Murphy

  	
   

  	
  By:

  	
  /s/    Geraldine
  A Henwood

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  James
  R. Murphy

  	
   

  	
  Geraldine
  A. Henwood  

  
	
   

  	
  Chief
  Executive Officer

  	
   

  	
  Chief
  Executive Officer

  
						

 

4Exhibit 10.3

 

SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

 

 

This Second
Amendment to Amended and Restated Credit Agreement (hereinafter referred to as
the “Amendment”) executed as of the 30th day of December,
2005, by and among Clayton Williams Energy Inc., a Delaware corporation (“CWEI”),
Southwest Royalties, Inc. (successor by merger to CWEI-SWR, Inc.), a Delaware
corporation (“SWR”, and together with CWEI and each of their respective
successors and permitted assigns, the “Borrowers” and each a “Borrower”),
Warrior Gas Co., a Texas corporation (“Warrior”), CWEI Acquisitions,
Inc. a Delaware corporation (“CWEI Acquisitions”), Romere Pass
Acquisition L.L.C., a Delaware limited liability company (“Romere”),
CWEI Romere Pass Acquisition Corp., a Delaware corporation (“Romere Corp”),
Blue Heel Company, a Delaware corporation (“Blue Heel”), and Tex-Hal
Partners, Inc., a Delaware corporation (“Tex-Hal” and together with
Warrior, CWEI Acquisitions, Romere, Romere Corp and Blue Heel and each of their
successors and permitted assigns, the “Guarantors” and each a “Guarantor”),
JPMorgan Chase Bank, N.A. (successor by merger to Bank One, N.A. (Illinois)), a
national banking association (“JPMorgan Chase”), each of the financial
institutions which is a party hereto (as evidenced by the signature pages to
this Amendment) or which may from time to time become a party to the Agreement
pursuant to the provisions of Section 14.3 thereof or any successor or
permitted assignee thereof (hereinafter collectively referred to as “Lenders”,
and individually, “Lender”), JPMorgan Chase, as Administrative Agent (in
its capacity as Administrative Agent and together with its successors in such
capacity, “Administrative Agent”). Capitalized terms used but not
defined in this Amendment have the meanings assigned to such terms in that
certain Amended and Restated Credit Agreement dated as of May 21, 2004, by and
among Borrowers, Guarantors, Administrative Agent and Lenders (as amended,
supplemented or otherwise modified from time to time, the “Agreement”).

 

WITNESSETH:

 

WHEREAS, the Borrowers and the Guarantors have
requested that the Administrative Agent and the Lenders amend the Agreement to (i)
increase the Borrowing Base to $150,000,000 and (ii) permit CWEI to make
investments in a drilling rig joint venture with Lariat Services, Inc. (“Lariat”)
through Larclay, LLC a newly formed limited liability company (“Larclay”)
to be owned in equal shares by CWEI and Lariat; and the Administrative Agent
and the Lenders (or at least the requisite percentage thereof) have agreed to
do so on the terms and conditions hereinafter set forth; and

 

NOW, THEREFORE, for
and in consideration of the mutual covenants and agreements herein contained
and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged and confessed, the Borrowers, the Guarantors, the
Administrative Agent and the Lenders, hereby agree as follows:

 

SECTION 1.         Amendments to the Agreement. Subject
to the satisfaction or waiver in writing of each condition precedent set forth
in Section 3 hereof, and in reliance on the representations, warranties,
covenants and agreements contained in this Amendment, the Agreement shall be
amended in the manner provided in this Section 1.

 

1

 

1.1          Additional Definitions. Article
I of the Agreement shall be and it hereby is amended by adding the
following definitions in the correct alphabetical order:

 

“Drilling
Venture” means the drilling rig joint venture among CWEI and Lariat through
Larclay.

 

“Larclay”
means Larclay, LLC, a Delaware limited liability company.

 

“Lariat”
means Lariat Services, Inc., a Texas corporation.

 

“Second
Amendment Effective Date” means December 30, 2005.

 

1.2          Borrowing Base.  Section
4.1 of the Agreement shall be and it hereby is amended in its entirety to
read as follows:

 

Borrowing Base. The
aggregate amount of credit available to the Borrowers under this Agreement
shall be limited by a Borrowing Base (herein so called) which shall be determined
by the Lenders at the times and in accordance with the standards and procedures
set forth in this Article IV. Subject to Section 4.2 hereof, during the period
from the Second Amendment Effective Date to the first Determination Date after
the Second Amendment Effective Date, the Borrowing Base shall be $150,000,000.

 

1.3          Notice
of Redetermination. Section 4 of the Agreement
shall be and it hereby is amended by adding the following as Section 4.6
of such section:

 

4.6          Notice of Redetermination. In
addition to notification of any Scheduled Redetermination of the Borrowing Base
pursuant to Section 4.2, promptly following any other redetermination of the
Borrowing Base pursuant to this Section 4 after the Second Amendment Effective
Date, the Administrative Agent shall notify Borrowers of the amount of the
redetermined Borrowing Base, which Borrowing Base shall be effective as of the
Determination Date specified in such notice, and such Borrowing Base shall
remain in effect for all purposes of this Agreement until the next
Determination Date.

 

1.4          Investments and Acquisitions. Section
8.15 of the Agreement shall be and it hereby is amended by deleting clause
(viii) and inserting the following as clauses (viii) and (ix) of such section:

 

(viii)       Investments by CWEI in the Drilling Venture, including loans,
advances or other extensions of credit to Lariat; provided that the amount
of such Investments made pursuant to this clause (viii) of Section 8.15 does
not exceed in the aggregate, $20,000,000 and the proceeds of such Investments
are used by Lariat to
make deposits on drilling rigs and related equipment to be acquired by Larclay
or Larclay’s Subsidiaries and by Larclay or Larclay’s Subsidiaries to acquire, own, operate and
maintain drilling rigs and related equipment.

 

2

 

(ix)         Other Investments not otherwise described in clauses (i) through (viii)
above; provided that, the aggregate amount of all other Investments made
pursuant to this clause (ix) outstanding at any time shall not exceed
$1,000,000 (calculated based on the original cost of such Investment).

 

SECTION 2.         Consent and Reaffirmation of Guarantors. By
their execution hereof, each Guarantor hereby (i) acknowledges receipt of this
Amendment, (ii) consents to the Borrowers’ execution and delivery hereof; (iii)
agrees to be bound hereby; (iv) affirms that nothing contained therein shall
modify in any respect whatsoever its guaranty of the obligations of the
Borrowers to Lenders pursuant to the terms of its Guaranty in favor of
Administrative Agent and the Lenders and (v) reaffirms that its Guaranty is and
shall continue to remain in full force and effect.

 

SECTION 3.         Conditions. The amendments
to the Agreement contained in Section 1 of this Amendment shall be effective
upon the satisfaction of each of the conditions set forth in this Section 3.

 

3.1          Execution and Delivery. Each
Borrower and each Guarantor shall have executed and delivered this Amendment.

 

3.2          Representations and Warranties.
The representations and warranties of each Borrower under the Agreement, as
amended by the Amendment are true and correct in all material respects as of
such date, as if then made (except to the extent that such representations and
warranties relate solely to an earlier date).

 

3.3          No Event of Default. No
Event of Default shall have occurred and be continuing nor shall any event have
occurred or failed to occur which, with the passage of time or service of
notice, or both, would constitute an Event of Default.

 

3.4          Other Documents. The
Administrative Agent shall have received such other instruments and documents
incidental and appropriate to the transaction provided for herein as the
Administrative Agent or its special counsel may reasonably request, and all
such documents shall be in form and substance satisfactory to the
Administrative Agent.

 

SECTION 4.         Representations and Warranties of Borrowers.
To induce the Lenders to enter into this Amendment, the Borrowers hereby
represent and warrant to the Lenders as follows:

 

4.1          Reaffirmation of Representations and
Warranties/Further Assurances. After giving effect to the
amendments herein, each representation and warranty of any Borrower or any
Guarantor contained in the Agreement or in any of the other Loan Documents is
true and correct in all material respects on the date hereof (except to the
extent such representations and warranties relate solely to an earlier date).

 

4.2          Corporate Authority; No Conflicts.
The execution, delivery and performance by each Borrower and each Guarantor (to
the extent a party hereto or thereto) of this Amendment and all documents,
instruments and agreements contemplated herein are within each such 

 

3

 

Borrower’s or
such Guarantor’s corporate or other organizational powers, have been duly
authorized by necessary action, require no action by or in respect of, or
filing with, any court or agency of government and do not violate or constitute
a default under any provision of any applicable law or other agreements binding
upon any Borrower or any Guarantor or result in the creation or imposition of
any Lien upon any of the assets of any Borrower or any Guarantor except for
Permitted Liens and otherwise as permitted in the Agreement.

 

4.3          Enforceability. This Amendment
constitutes the valid and binding obligation of each Borrower and each
Guarantor enforceable in accordance with its terms, except as (i) the
enforceability thereof may be limited by bankruptcy, insolvency or similar laws
affecting creditor’s rights generally, and (ii) the availability of equitable
remedies may be limited by equitable principles of general application.

 

SECTION 5.         Miscellaneous.

 

5.1          Reaffirmation of Loan Documents and Liens.
Any and all of the terms and provisions of the Agreement and the Loan Documents
shall, except as amended and modified hereby, remain in full force and effect. Each
Borrower hereby agrees that the amendments and modifications herein contained
shall in no manner affect or impair the liabilities, duties and obligations of
such Borrower or any Guarantor under the Agreement and the other Loan Documents
or the Liens securing the payment and performance thereof.

 

5.2          Parties in Interest. All of
the terms and provisions of this Amendment shall bind and inure to the benefit
of the parties hereto and their respective successors and assigns.

 

5.3          Legal Expenses. The
Borrowers hereby agree, jointly and severally, to pay all reasonable fees and
expenses of counsel to the Administrative Agent incurred by the Administrative
Agent in connection with the preparation, negotiation and execution of this
Amendment and all related documents.

 

5.4          Counterparts. This
Amendment may be executed in one or more counterparts and by different parties
hereto in separate counterparts each of which when so executed and delivered
shall be deemed an original, but all such counterparts together shall
constitute but one and the same instrument; signature pages may be detached
from multiple separate counterparts and attached to a single counterpart so that
all signature pages are physically attached to the same document. However, this
Amendment shall bind no party until the Borrowers, the Guarantors, the Lenders
(or at least the requisite percentage thereof), and the Administrative Agent
have executed a counterpart. Delivery of photocopies of the signature pages to
this Amendment by facsimile or electronic mail shall be effective as delivery
of manually executed counterparts of this Amendment.

 

5.5          Complete Agreement. THIS
AMENDMENT, THE AGREEMENT, AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL
AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR,
CONTEMPORANEOUS OR ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL
AGREEMENTS BETWEEN THE PARTIES.

 

4

 

5.6          Headings. The headings,
captions and arrangements used in this Amendment are, unless specified
otherwise, for convenience only and shall not be deemed to limit, amplify or
modify the terms of this Amendment, nor affect the meaning thereof.

 

 

[Signature Pages Follow]

 

5

 

IN WITNESS WHEREOF,
the parties have caused this Second Amendment to Amended and Restated Credit
Agreement to be duly executed as of the date first above written.

 

 

	
   

  	
  BORROWERS:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  CLAYTON WILLIAMS ENERGY, INC.

  	
   

  
	
   

  	
  a Delaware
  corporation

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark
  Tisdale, Vice President and General Counsel

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  SOUTHWEST ROYALTIES, INC.

  	
   

  
	
   

  	
  a Delaware
  limited liability company

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark
  Tisdale, Vice President

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  GUARANTORS:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  WARRIOR GAS CO.

  	
   

  
	
   

  	
  a Texas
  corporation

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark
  Tisdale, Secretary

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  CWEI ACQUISITIONS, INC.

  	
   

  
	
   

  	
  a Delaware
  corporation

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark
  Tisdale, Secretary

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  ROMERE PASS ACQUISITION L.L.C.

  	
   

  
	
   

  	
  a Delaware
  limited liability company

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark
  Tisdale, Vice President

  	
   

  

 

 

	
   

  	
  CWEI ROMERE PASS ACQUISITION CORP.

  	
   

  
	
   

  	
  a Delaware corporation

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark Tisdale, Vice President

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  BLUE HEEL COMPANY

  	
   

  
	
   

  	
  a Delaware
  corporation

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark
  Tisdale, Vice President

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  TEX-HAL PARTNERS, INC.

  	
   

  
	
   

  	
  a Delaware corporation

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Mark Tisdale

  	
   

  
	
   

  	
   

  	
  Mark Tisdale, Vice President

  	
   

  

 

 

	
   

  	
  JPMORGAN CHASE BANK, N.A.,

  	
   

  
	
   

  	
  (successor
  by merger to Bank One, N.A. (Illinois)),

  	
   

  
	
   

  	
  as
  Administrative Agent and a Lender

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Wm. Mark Cranmer

  	
   

  
	
   

  	
  Name:

  	
  Wm. Mark Cranmer

  	
   

  
	
   

  	
  Title:

  	
  Vice
  President

  	
   

  
					

 

 

	
   

  	
  BANK OF SCOTLAND

  	
   

  
	
   

  	
  as Co-Agent
  and a Lender

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Karen Welch

  	
   

  
	
   

  	
  Name:

  	
   

  	
  Karen Welch

  	
   

  
	
   

  	
  Title:

  	
   

  	
  Assistant Vice President

  	
   

  
								

 

 

	
   

  	
  UNION BANK OF CALIFORNIA, N.A.

  	
   

  
	
   

  	
  as
  Syndication Agent and a Lender

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Kimberly Coil

  	
   

  
	
   

  	
  Name:

  	
  Kimberly Coil

  	
   

  
	
   

  	
  Title:

  	
  Vice President

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Ali Ahmed

  	
   

  
	
   

  	
  Name:

  	
  Ali Ahmed

  	
   

  
	
   

  	
  Title:

  	
  Vice President

  	
   

  

 

 

	
   

  	
  BNP PARIBAS

  	
   

  
	
   

  	
  as
  Documentation Agent and a Lender

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Betsy Jocher

  	
   

  
	
   

  	
  Name:

  	
  Betsy Jocher

  	
   

  
	
   

  	
  Title:

  	
  Vice President

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Russell Otts

  	
   

  
	
   

  	
  Name:

  	
  Russell Otts

  	
   

  
	
   

  	
  Title:

  	
  Vice President

  	
   

  

 

 

	
   

  	
  FORTIS CAPITAL CORP.

  	
   

  
	
   

  	
  as a Lender

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Michele Jones

  	
   

  
	
   

  	
  Name:

  	
  Michele Jones

  	
   

  
	
   

  	
  Title:

  	
  Senior Vice President

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Darrell Holley

  	
   

  
	
   

  	
  Name:

  	
  Darrell Holley

  	
   

  
	
   

  	
  Title:

  	
  Managing Director

  	
   

  

 

 

	
   

  	
  COMERICA BANK

  	
   

  
	
   

  	
  as a Lender

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Matthew J. Purchase

  	
   

  
	
   

  	
  Name:

  	
  Matthew J. Purchase

  	
   

  
	
   

  	
  Title:

  	
  Vice President

  	
   

  

 

 

	
   

  	
  GUARANTY BANK

  	
   

  
	
   

  	
  as a Lender

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ John A. Clark

  	
   

  
	
   

  	
  Name:

  	
  John A. Clark

  	
   

  
	
   

  	
  Title:

  	
  Senior Vice President

  	
   

  

 

 

	
   

  	
  NATEXIS BANQUES POPULAIRES

  	
   

  
	
   

  	
  as a Lender

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Donovan C. Broussard

  	
   

  
	
   

  	
  Name:

  	
  Donovan C. Broussard

  	
   

  
	
   

  	
  Title:

  	
  Vice President & Group Manager

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Louis P. Laville, III

  	
   

  
	
   

  	
  Name:

  	
  Louis P. Laville, III

  	
   

  
	
   

  	
  Title:

  	
  Vice President and Group Manager

  	
   

  

 

 

	
   

  	
  BANK OF TEXAS, N.A.

  	
   

  
	
   

  	
  as a Lender

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ J. Michael Delbridge

  	
   

  
	
   

  	
  Name:

  	
  J. Michael Delbridge

  	
   

  
	
   

  	
  Title:

  	
  Senior Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]